All Stories

  1. Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

    Article • Journal of Medical Economics, January 2019, Taylor & Francis

    Edward Gibson

  2. Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

    Article • ClinicoEconomics and Outcomes Research, March 2018, Dove Medical Press

    Edward Gibson

  3. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey

    Article • Developmental Medicine & Child Neurology, October 2017, Wiley

    Edward Gibson

  4. Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region

    Article • Journal of Market Access & Health Policy, January 2017, Taylor & Francis

    Edward Gibson